Because of the finding of GRB10 mutation in case #2, mutational analysis of GRB10 was also performed on tumor from case #3 (who also achieved a CR after IGF1R inhibitor therapy) and, remarkably, was also positive by Sanger sequencing. Here, GRB10 is linked to neoplasm.